Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jac/dkq109PMID 20375031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and Efficacy of Daptomycin in the Treatment of Osteomyelitis: Results from the CORE® Registry

  2009cited by this paper
• Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy.

  2009cited by this paper
• Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

  2009cited by this paper
• High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.

  2009cited by this paper
• Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy

  2009cited by this paper
• Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus

  2009cited by this paper
• Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).

  2009cited by this paper
• In Vivo Microdialysis Study of the Penetration of Daptomycin into Soft Tissues in Diabetic versus Healthy Volunteers

  2008cited by this paper
• Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis

  2008cited by this paper
• Daptomycin in bone and joint infections: a review of the literature

  2008cited by this paper
• Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

  2007cited by this paper
• Pharmacokinetics of Single- and Multiple-Dose Oral Clarithromycin in Soft Tissues Determined by Microdialysis

  2007cited by this paper
• Influence of Morbid Obesity on the Single-Dose Pharmacokinetics of Daptomycin

  2007cited by this paper
• Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial Agents

  2007cited by this paper
• Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.

  2007cited by this paper
• Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac Surgery

  2006cited by this paper
• Diagnosis and Treatment of Diabetic Foot Infections

  2006cited by this paper
• Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.

  2006cited by this paper
• Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers

  2006cited by this paper
• In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci.

  2006cited by this paper
• Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin

  2006cited by this paper
• Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus

  2005cited by this paper
• Microdialysis

  2005cited by this paper
• Daptomycin: A cyclic lipopeptide antimicrobial agent

  2004cited by this paper
• Diagnosis and treatment of diabetic foot infections.

  2004cited by this paper
• Microdialysis

  2004cited by this paper
• Synergy of Daptomycin with Oxacillin and Other β-Lactams against Methicillin-Resistant Staphylococcus aureus

  2004cited by this paper
• In Vivo Pharmacodynamic Activity of Daptomycin

  2004cited by this paper
• Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.

  2003cited by this paper
• Penetration of Moxifloxacin into Healthy and Inflamed Subcutaneous Adipose Tissues in Humans

  2003cited by this paper
• Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects

  2003cited by this paper
• Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease

  2001cited by this paper
• Glomerular filtration rate measurements in clinical trials

  1993cited by this paper
• Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group.

  1993cited by this paper
• In vitro activity of daptomycin-metronidazole combinations against mixed bacterial cultures: Reduced activity of metronidazole againstBacteroides species in the presence ofEnterococcus faecalis

  1990cited by this paper
• Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits

  1989cited by this paper
• Diabetes mellitus, diagnosis and treatment

  1981cited by this paper

• Comprehensive pharmacokinetic/pharmacodynamic analysis of commercially available premixed daptomycin preparations against Staphylococcus aureus and Enterococcus spp. bloodstream infections using Monte Carlo simulation in adult patients

  2026cites this paper
• PK/PD Analysis of High-Dose Daptomycin Use in the Treatment of Bone and Joint Infections: Data from a Real-World Setting

  2025cites this paper
• Not All in Vein: Oral Antibiotics for Diabetic Foot Osteomyelitis: A Narrative Review

  2025influential citation
• Management of methicillin-resistant Staphylococcus aureus bloodstream infections: a comprehensive narrative review of available evidence focusing on current controversies and the challenges ahead

  2025cites this paper
• Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults

  2024cites this paper
• Dynamic distribution of systemically administered antibiotics in orthopeadically relevant target tissues and settings

  2024cites this paper
• Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach

  2023influential citation
• What clindamycin dose should be administered by continuous infusion during combination therapy with rifampicin? A prospective population pharmacokinetics study.

  2023cites this paper
• Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence

  2023cites this paper
• Microdialysis as a tool for antibiotic assessment in patients with diabetic foot: a review

  2023cites this paper
• Daptomycin Pharmacokinetics in Blood and Wound Fluid in Critical Ill Patients with Left Ventricle Assist Devices

  2023cites this paper
• Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review—Part I

  2022cites this paper
• Penetration of Vancomycin into Noninfected Bone in Patients Undergoing Total Joint Arthroplasty Evaluated by a Minimal Physiologically Based Population Pharmacokinetic Modeling Approach.

  2022cites this paper
• Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin

  2022cites this paper
• Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone Tissues

  2022cites this paper
• The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review

  2022cites this paper
• Population pharmacokinetics of daptomycin in patients with bone and joint infection: minimal effect of rifampicin co-administration and confirmation of a sex difference.

  2021cites this paper
• Low prevalence of tissue detection of cefepime and daptomycin used as empirical treatment during revision for periprosthetic joint infections: results of a prospective multicenter study

  2021cites this paper
• Microdialysis: an emerging technique for pharmacokinetic–pharmacodynamic profiling

  2021cites this paper
• Antibiotics in Necrotizing Soft Tissue Infections

  2021cites this paper
• Lipid-based nanosystems for targeting bone implant-associated infections: current approaches and future endeavors

  2020cites this paper
• Susceptibility of monomicrobial or polymicrobial biofilms derived from infected diabetic foot ulcers to topical or systemic antibiotics in vitro

  2020cites this paper
• Clinical Pharmacokinetics of Daptomycin

  2020cites this paper
• Silver Sulfadiazine Eradicates Antibiotic-Tolerant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms in Patients with Infected Diabetic Foot Ulcers

  2020cites this paper
• Implications of Glycopeptide and Lipopeptide Antibiotics on Asthma Exacerbations in a Patient With Hyper-IgE Syndrome and Chronic Severe Asthma: A Case Report

  2020cites this paper
• Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery.

  2020cites this paper
• Infection Protocols for Implants.

  2019cites this paper
• Bone penetration of daptomycin in diabetic patients with bacterial foot infections.

  2019cites this paper
• Linezolid versus daptomycin treatment for periprosthetic joint infections: a retrospective cohort study

  2019cites this paper
• Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant

  2019cites this paper
• Effect of high blood glucose level on the antimicrobial activity of daptomycin against Staphylococcus aureus in streptozotocin-induced diabetic mice.

  2019cites this paper
• An in vitro biofilm model of Staphylococcus aureus infection of bone

  2019cites this paper
• Antibiotic penetration into bone and joints: An updated review.

  2019cites this paper
• Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation

  2019cites this paper
• Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review

  2019cites this paper
• Genetic polymorphisms of ABCB1 (P-glycoprotein) as a covariate influencing daptomycin pharmacokinetics: a population analysis in patients with bone and joint infection

  2019cites this paper
• Systemic antibiotic treatment of chronic osteomyelitis in adults.

  2019cites this paper
• Bone, intervertebral disc and subcutaneous adipose tissue pharmacokinetics of vancomycin obtained by microdialysis PhD thesis

  2019cites this paper
• Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus

  2018cites this paper
• Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms

  2018cites this paper
• Bone and Joint Tissue Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery

  2018cites this paper
• Advance Publication by J-STAGE Japanese Journal of Infectious Diseases

  2017cites this paper
• Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection

  2017cites this paper
• Obesity and skin and soft tissue infections: how to optimize antimicrobial usage for prevention and treatment?

  2017cites this paper
• Single‐dose bone pharmacokinetics of vancomycin in a porcine implant‐associated osteomyelitis model

  2017cites this paper
• Bone and subcutaneous adipose tissue pharmacokinetics of vancomycin in total knee replacement patients

  2017cites this paper
• Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature

  2017cites this paper
• Microcalorimetric detection of staphylococcal biofilm growth on various prosthetic biomaterials after exposure to daptomycin

  2017cites this paper
• Effects of Implant-Associated Osteomyelitis on Cefuroxime Bone Pharmacokinetics: Assessment in a Porcine Model.

  2016cites this paper
• Diabetic foot syndrome: importance of microbiological monitoring and antimicrobial penetration of chemotherapeutic agents into the soft tissue lower limb in determining the treatment

  2016cites this paper
• Enfermedades Infecciosas y Microbiología Clínica

  2016cites this paper
• Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review

  2016cites this paper
• Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections

  2016cites this paper
• Pharmacokinetics of single-dose cefuroxime in porcine intervertebral disc and vertebral cancellous bone determined by microdialysis.

  2016cites this paper
• Pharmacodynamics of Daptomycin

  2016cites this paper
• Polymers as Carriers of Gentamicin in Traumatology and Orthopedic Surgery - Current State Of Knowledge.

  2016cites this paper
• Development of a Novel Collagen Wound Model To Simulate the Activity and Distribution of Antimicrobials in Soft Tissue during Diabetic Foot Infection

  2016cites this paper
• Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE

  2016cites this paper
• Antibiotic Tissue Penetration in Diabetic Foot Infections A Review of the Microdialysis Literature and Needs for Future Research.

  2015cites this paper
• Pharmacokinetics and Pharmacodynamics of Antibiotics in Bone

  2015cites this paper
• Plasma, Subcutaneous Adipose Tissue, Vertebral Cancellous Bone and Intervertebral Disc Pharmacokinetics of Cefuroxime

  2015cites this paper
• Antimicrobial efficacy of combined clarithromycin plus daptomycin against biofilms-formed methicillin-resistant Staphylococcus aureus on titanium medical devices.

  2015cites this paper
• Diabetic Foot Infection

  2015cites this paper
• Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), Lipopeptides (Daptomycin), and Lipoglycopeptides (Telavancin)

  2015cites this paper
• Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin

  2015cites this paper
• Microdialysis Techniques In Pharmacokinetic and Biomarker Studies. Past, Present and Future Directions. A Review.

  2015cites this paper
• Heterogeneity of Genetic Pathways toward Daptomycin Nonsusceptibility in Staphylococcus aureus Determined by Adjunctive Antibiotics

  2015cites this paper
• The empiric and prudent anti-microbial therapy used in the patients with vascular peripheral disease

  2015cites this paper
• [Potential utility of ceftaroline fosamil in osteoarticular infections].

  2014cites this paper
• Recommendations for the treatment of osteomyelitis

  2014cites this paper
• Penetration of Daptomycin into Bone and Synovial Fluid in Joint Replacement

  2014influential citation
• Pharmacokinetics of Cefuroxime in Porcine Cortical and Cancellous Bone Determined by Microdialysis

  2014cites this paper
• Pharmacokinetics of Vancomycin in Porcine Cancellous and Cortical Bone Determined by Microdialysis Research

  2014influential citation
• Antibiotics in Treatment of Periprosthetic Joint Infections

  2014cites this paper
• Protocolo de tratamiento empírico de la osteomielitis

  2014cites this paper
• Obtained by Microdialysis - a Porcine Study

  2014cites this paper
• Chapter 3 Pharmacokinetics and Pharmacodynamics of Antibiotics in Bone

  2014influential citation
• High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study.

  2014cites this paper
• A Comprehensive Review on the Pharmacokinetics of Antibiotics in Interstitial Fluid Spaces in Humans: Implications on Dosing and Clinical Pharmacokinetic Monitoring

  2014cites this paper
• Daptomycin versus vancomycin for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA): a nested case–control study

  2013cites this paper
• Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORESM database

  2013cites this paper
• Periprosthetic Joint Infections: Clinical and Bench Research

  2013cites this paper
• The potential role of newer gram‐positive antibiotics in the setting of osteomyelitis of adults

  2013cites this paper
• Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn

  2013cites this paper
• 2012 infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections.

  2013cites this paper
• Evaluation Of The Use Of Daptomycin In Diabetic Foot Infections With Osteomyelitis

  2012cites this paper
• Diabetic foot infections: the role of microbiology and antibiotic treatment.

  2012cites this paper
• Daptomicina en el contexto de la resistencia a los antimicrobianos en bacterias grampositivas

  2012cites this paper
• 2012 Infectious Diseases of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections a

  2012cites this paper
• Medical Management of Diabetic Foot Infections

  2012cites this paper
• [Daptomycin in complicated skin and soft tissue infections].

  2012cites this paper
• Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa

  2012cites this paper
• Antibiotische Therapie von Enterokokken-Infektionen in der Gastroenterologie mit Daptomycin − erste Erfahrungen aus der Registerstudie EU-CORE (European Cubicin® Outcomes Registry and Experience)

  2012cites this paper
• [Daptomycin in diabetic patients].

  2012cites this paper
• Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease

  2012cites this paper
• Diabetic Foot Infections: Microbiology and Antibiotic Therapy

  2012cites this paper
• Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics

  2012cites this paper
• 2012 Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections a

  2012cites this paper
• [Daptomycin in the context of antimicrobial resistance in Gram-positive bacteria].

  2012cites this paper
• Combinations with Other Antibiotics Staphylococcus aureus Using Resistance in Methicillin-Resistant Altering the Proclivity towards Daptomycin

  2012cites this paper